Clinical Trials Directory

Trials / Conditions / Colorectal Cancer Recurrent

Colorectal Cancer Recurrent

16 registered clinical trials studyying Colorectal Cancer Recurrent — 7 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Dose-Expansion Trial of Intravenous HNF4α srRNA for Unresectable or Metastatic Colorectal Cancer
NCT07050394
Shanghai Changzheng HospitalEARLY_Phase 1
RecruitingTrifluridine/Tipiracil Plus Regorafenib vs Trifluridine/Tipiracil Plus Bevacizumab for Refractory Metastatic C
NCT06992648
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityPhase 3
RecruitingGa-68-FAPI-46 PET for CRC Recurrence Detection in Elevated CEA
NCT06769828
Koo Foundation Sun Yat-Sen Cancer CenterN/A
RecruitingSplicing-based Predictive Learning for Individual Chemotherapy Evaluation in Colorectal Cancer
NCT07226115
City of Hope Medical Center—
Completed[68Ga]Ga-GZP PET for Early Response Prediction in Colorectal Cancer During Neoadjuvant Therapy
NCT06982053
Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyN/A
RecruitingLeflunomide or Combination of MEK Inhibitor and Hydroxychloroquine for Refractory Patients With RAS Mutations
NCT06229340
N.N. Petrov National Medical Research Center of OncologyPhase 2
RecruitingDevelopment and Validation of Microbiota and Metabolite-based Prediction Model for Recurrence of High-risk Col
NCT06957626
Peking Union Medical College Hospital—
CompletedEarly-Onset Colorectal Cancer Recurrence
NCT06271980
City of Hope Medical Center—
CompletedExosome-based Detection of Molecular Residual Disease in Stage II-III Colorectal Cancer
NCT06654622
City of Hope Medical Center—
RecruitingStage II/III Colorectal Cancer Recurrence
NCT06314958
City of Hope Medical Center—
CompletedPredicting Local and Distant Recurrence in T1 Colorectal Cancer
NCT06314971
City of Hope Medical Center—
UnknownCamrelizumab Combined With Apatinib in the Treatment of Patients With Advanced Gastric Cancer and Colorectal C
NCT04067986
Zhongshan Hospital Xiamen UniversityPhase 1 / Phase 2
CompletedTo Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of YYB101 With Irinotecan, Patie
NCT04368507
CellabMEDPhase 1 / Phase 2
CompletedSafety and Efficacy Study of Famitinib in Patients With Advanced Colorectal Adenocarcinoma（FACT）
NCT02390947
Jiangsu HengRui Medicine Co., Ltd.Phase 3
CompletedA Study of Famitinib in Patients With Advanced Colorectal Cancer
NCT01762293
Jiangsu HengRui Medicine Co., Ltd.Phase 2
CompletedMicrobiome and Colorectal Cancer Recurrence
NCT07057076
Hospital del Mar—